Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAIYUN: As-needed PT027 versus PT007 in symptomatic Chinese adults with asthma
ChiCTR2400085445Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salbutamol + budesonide and albuterol sulfate in asthma (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Time to first severe asthma exacerbation, Salbutamol reversibility test and 1 more. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
salbutamol + budesonidealbuterol sulfate
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2400085445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085445.